Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.145 CAD | 0.00% | +3.57% | +81.25% |
06-25 | Kane Biotech Signs License Agreement with I-MED Pharma | MT |
06-25 | Kane Biotech Signs Worldwide License Agreement with I-MED Pharma Inc | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+81.25% | 14.07M | |
+38.36% | 52.5B | |
+36.73% | 39.31B | |
-8.63% | 39.01B | |
+25.46% | 28.2B | |
-11.17% | 26.57B | |
+11.44% | 26.2B | |
+45.09% | 14.15B | |
+32.93% | 12.62B | |
-5.30% | 11.74B |
- Stock Market
- Equities
- KNE Stock
- News Kane Biotech Inc.
- Kane Biotech Brief: Total revenue for three months ended September 30, 2023 was $717,852, an increase of 26% compared to $571,686 in three months ended September 30, 2022